ATE420624T1 - Pharmazeutische zusammensetzungen zurbehandlung von augenerkrankungen - Google Patents

Pharmazeutische zusammensetzungen zurbehandlung von augenerkrankungen

Info

Publication number
ATE420624T1
ATE420624T1 AT03809756T AT03809756T ATE420624T1 AT E420624 T1 ATE420624 T1 AT E420624T1 AT 03809756 T AT03809756 T AT 03809756T AT 03809756 T AT03809756 T AT 03809756T AT E420624 T1 ATE420624 T1 AT E420624T1
Authority
AT
Austria
Prior art keywords
treatment
pharmaceutical compositions
eye diseases
nanoparticles
ophthalmic
Prior art date
Application number
AT03809756T
Other languages
English (en)
Inventor
Maria Gasco
Gian Zara
Marco Saettone
Original Assignee
Gasco Maria Rosa
Zara Gian Paolo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gasco Maria Rosa, Zara Gian Paolo filed Critical Gasco Maria Rosa
Application granted granted Critical
Publication of ATE420624T1 publication Critical patent/ATE420624T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03809756T 2002-10-31 2003-10-31 Pharmazeutische zusammensetzungen zurbehandlung von augenerkrankungen ATE420624T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002323A ITMI20022323A1 (it) 2002-10-31 2002-10-31 Composizioni farmaceutiche atte al trattamento di malattie oftalmiche.

Publications (1)

Publication Number Publication Date
ATE420624T1 true ATE420624T1 (de) 2009-01-15

Family

ID=32211395

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03809756T ATE420624T1 (de) 2002-10-31 2003-10-31 Pharmazeutische zusammensetzungen zurbehandlung von augenerkrankungen

Country Status (9)

Country Link
US (1) US20060024374A1 (de)
EP (1) EP1567125B1 (de)
CN (1) CN100594888C (de)
AT (1) ATE420624T1 (de)
AU (1) AU2003301747A1 (de)
CA (1) CA2504199C (de)
DE (1) DE60325887D1 (de)
IT (1) ITMI20022323A1 (de)
WO (1) WO2004039351A2 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2526362C (en) * 2003-05-20 2012-10-09 James F. Collins Ophthalmic drug delivery system
US8545463B2 (en) * 2003-05-20 2013-10-01 Optimyst Systems Inc. Ophthalmic fluid reservoir assembly for use with an ophthalmic fluid delivery device
US20060182783A1 (en) * 2004-04-30 2006-08-17 Allergan, Inc. Sustained release intraocular drug delivery systems
ITMI20041151A1 (it) * 2004-06-09 2004-09-09 Maria Rosa Gasco Nanoparticelle lipidiche come agenti veicolanti per acidi nucleici procedimento per la loro preparazione e loro uso
EP1674085A1 (de) * 2004-12-22 2006-06-28 Universite Libre De Bruxelles Feste Lipidteilchen als pharmazeutische annehmbare Füllstoffe oder Träger zur Inhalation
EP1993365B1 (de) * 2006-03-06 2013-05-08 The Regents of the University of California Biologisch verfügbare curcuminoid-formulierungen zur behandlung von alzheimer-krankheit und anderen mit dem alter zusammenhängenden krankheiten
WO2009013563A2 (en) * 2006-11-13 2009-01-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases or disorders of the eye
CA2689042A1 (en) * 2007-02-16 2008-08-28 Merck & Co., Inc. Compositions and methods for potentiated activity of biologicaly active molecules
US20090061009A1 (en) * 2007-08-29 2009-03-05 Joseph Schwarz Composition and Method of Treatment of Bacterial Infections
WO2009087678A2 (en) * 2007-12-24 2009-07-16 Sun Pharma Advanced Research Company Limited Nanodispersion
US20090212133A1 (en) * 2008-01-25 2009-08-27 Collins Jr James F Ophthalmic fluid delivery device and method of operation
ITMI20090284A1 (it) * 2009-02-26 2010-08-27 Consiglio Nazionale Ricerche Uso di inibitori della serina palmitoiltrasferasi per la prevenzione e il rallentamento delle degenerazioni retiniche ereditarie e relative composizioni
US8912236B2 (en) * 2009-03-03 2014-12-16 Alcon Research, Ltd. Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye
EP2442805A4 (de) 2009-06-19 2012-11-21 Sun Pharma Advanced Res Co Ltd Nanodispersion aus einem medikament und verfahren zu ihrer herstellung
US10154923B2 (en) 2010-07-15 2018-12-18 Eyenovia, Inc. Drop generating device
EP2485691B1 (de) 2010-07-15 2020-03-18 Eyenovia, Inc. Verabreichung einer augenmedizin
JP2013531548A (ja) 2010-07-15 2013-08-08 コリンシアン オフサルミック，インコーポレイティド 遠隔治療及び遠隔モニタリングを実施する方法及びシステム
AU2011278934B2 (en) 2010-07-15 2015-02-26 Eyenovia, Inc. Drop generating device
RU2460517C1 (ru) * 2011-07-14 2012-09-10 Федеральное государственное учреждение "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" Фармацевтическая композиция для комплексного лечения заболеваний глазной поверхности у больных с первичной открытоугольной глаукомой
JP6105621B2 (ja) 2011-12-12 2017-03-29 アイノビア，インコーポレイティド 高弾性高分子エジェクタ機構、エジェクタ装置及びそれらの使用方法
EP2892570B1 (de) 2012-09-07 2019-02-27 Bracco Imaging S.p.A Paramagnetische feste lipidnanopartikel zur kernspinnresonanzbildgebung, die amphiphile metallkomplexe enthalten
US9511341B2 (en) 2013-08-30 2016-12-06 Sunny Pharmtech Inc. Method for preparing acetazolamide sodium powder
EP3148331B1 (de) * 2014-05-30 2020-12-23 OMS Investments, Inc. Verfahren zur herstellung von wasserbasierten nanodispersionszusammensetzungen
ES2905458T3 (es) * 2014-10-09 2022-04-08 Distretto Tecnologico Sicilia Micro E Nano Sistemi S C A R L Formulaciones nanoestructuradas para la administración de silibinina y otros principios activos para el tratamiento de enfermedades oculares
JP7227163B2 (ja) 2017-06-10 2023-02-21 アイノビア，インコーポレイティド 流体を取扱い、目に流体を送出するための方法および装置
EP4034645A1 (de) 2019-09-23 2022-08-03 Ecole Polytechnique Federale De Lausanne (Epfl) Behandlung und prävention von altersbedingten erkrankungen und/oder von alterung durch hemmung von sphingolipiden
US12161585B2 (en) 2019-12-11 2024-12-10 Eyenovia, Inc. Systems and devices for delivering fluids to the eye and methods of use

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904649A (en) * 1986-05-23 1990-02-27 New England Medical Center Hospitals, Inc. Method and solution for treating glaucoma
FR2657018A1 (fr) * 1990-01-12 1991-07-19 Merck Sharp & Dohme Composition ophtalmique fluide a base de microparticules lipidiques contenant au moins un principe actif et son procede de preparation.
US5250236A (en) * 1991-08-05 1993-10-05 Gasco Maria R Method for producing solid lipid microspheres having a narrow size distribution
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
US5622932A (en) * 1995-05-05 1997-04-22 Eli Lilly And Company IGF-1 superagonists
US5891467A (en) * 1997-01-31 1999-04-06 Depotech Corporation Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
US5811446A (en) * 1997-04-18 1998-09-22 Cytos Pharmaceuticals Llc Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
IT1292142B1 (it) * 1997-06-12 1999-01-25 Maria Rosa Gasco Composizione farmaceutica in forma di microparticelle lipidiche solide atte alla somministrazione parenterale
IT1296914B1 (it) * 1997-12-01 1999-08-03 Maria Rosa Gasco Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera
IT1298575B1 (it) * 1998-02-06 2000-01-12 Vectorpharma Int Composizioni farmaceutiche in forma di nanoparticelle comprendenti sostanze lipidiche e sostanze antifiliche e relativo processo di
US7153525B1 (en) * 2000-03-22 2006-12-26 The University Of Kentucky Research Foundation Microemulsions as precursors to solid nanoparticles
US20030072794A1 (en) * 2000-06-09 2003-04-17 Teni Boulikas Encapsulation of plasmid DNA (lipogenes™) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes
US6720008B2 (en) * 2002-01-22 2004-04-13 Pr Pharmaceuticals, Inc. Composition and method for the encapsulation of water-soluble molecules into nanoparticles
US7067479B2 (en) * 2002-09-30 2006-06-27 Bausch & Lomb Inc. Compositions with enhanced antimicrobial efficacy against E. coli

Also Published As

Publication number Publication date
EP1567125B1 (de) 2009-01-14
CA2504199C (en) 2011-10-18
AU2003301747A8 (en) 2004-05-25
ITMI20022323A1 (it) 2004-05-01
CN100594888C (zh) 2010-03-24
AU2003301747A1 (en) 2004-05-25
WO2004039351A2 (en) 2004-05-13
US20060024374A1 (en) 2006-02-02
EP1567125A2 (de) 2005-08-31
CA2504199A1 (en) 2004-05-13
CN1756529A (zh) 2006-04-05
WO2004039351A3 (en) 2004-07-08
DE60325887D1 (de) 2009-03-05

Similar Documents

Publication Publication Date Title
ATE420624T1 (de) Pharmazeutische zusammensetzungen zurbehandlung von augenerkrankungen
DK1385452T3 (da) Anordning til tilförsel af et ophthalmisk medikament
Yaylali et al. Comparative study of 0.1% olopatadine hydrochloride and 0.5% ketorolac tromethamine in the treatment of seasonal allergic conjunctivitis
DE60334692D1 (de) Ophthalmologische zubereitung enthaltend roflumilast in der behandlung von krankheiten der augen
BRPI9811989B8 (pt) uso do ácido 9-cis retinóico para a fabricação de um medicamento
WO2002041883A3 (en) As-needed administration of tricyclic and other non-sri antidepressant drugs to treat premature ejaculation
DE60143393D1 (de) Modifizierte formen pharmazeutisch aktiver agenzien und verwendungen dafür
AR039130A2 (es) Metodo de administracion de un agente farmaceuticamente activo a un ojo humano
CA2508303A1 (en) Drug delivery system using subconjunctival depot
AR041725A1 (es) Prevencion, tratamiento de la enfermedad sinucleinopatica y composicion farmacologica
CA2440764A1 (en) Combination of brimonidine and timolol for topical ophthalmic use
BR0206568A (pt) Novo método e composições para o tratamento local de doença de meniere, de zumbido no ouvido e/ou de perda de audição
DE60233898D1 (de) Transdermales therapeutisches system für parkinson-krankheit mit hohen rotigotin-plasmaspiegeln
AR015744A1 (es) Uso de dexmedetomidina para sedacion en terapia intensiva
BRPI0406858A (pt) Liberação controlada de agentes altamente solúveis
CN102066402A (zh) 肽衍生物以及含有肽衍生物的用于促进泪液分泌的组合物
BR0209063A (pt) Medicamentos e kits de uso medicinal
AR036877A1 (es) Formulacion farmaceutica
AU2003290015A1 (en) Mastitis treatment
SE9301877D0 (sv) In situ gel for therapeutic use
NO20013605D0 (no) Preparat for vorter
JPH0977656A (ja) 点眼用エアゾル組成物
MA28036A1 (fr) Utilisation d'oxcarbazepine dans le traitement de la douleur liee a la neuropathie diabetique et dans l'amelioration du sommeil
AR039604A1 (es) Utilizacion de una sal de acido l-ascorbico para la preparacion de una composicion farmaceutica, para uso oftalmico topico, capaz de mejorar el nivel de acido l-ascorbico en el ojo
BR122014030158B8 (pt) formulação farmacêutica

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties